Multicenter Assessment of the Pancreas in Type 1 Diabetes
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Alvin C. Powers, MD
Vanderbilt University Medical Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- St. Vincent'S Institute of Medical Research
Melbourne, Victoria, Australia
- University of Colorado, Barbara Davis Center
Aurora, Colorado, United States
- University of Chicago, Kovler Diabetes Center
Chicago, Illinois, United States
- Vanderbilt University Medical Center
Nashville, Tennessee, United States
- University of Texas at Austin, Dell Medical School
Austin, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 19 Feb 2014
- Primary completion
- 31 Dec 2028
- Completion
- 31 Dec 2050
- Last update posted
- 31 Oct 2025
- Registered enrollment
- 250
- Registry id
- NCT03585153
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.